| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |